A superiority, randomized, open-label, multi-center study to compare the efficacy and safety of adjunctive zonisamide vs replacement with zonisamide of the last added antiepileptic drug in patients with partial onset seizures.

Trial Profile

A superiority, randomized, open-label, multi-center study to compare the efficacy and safety of adjunctive zonisamide vs replacement with zonisamide of the last added antiepileptic drug in patients with partial onset seizures.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2014

At a glance

  • Drugs Zonisamide (Primary) ; Antiepileptic drugs
  • Indications Partial epilepsies
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ADONE
  • Sponsors Eisai S.r.l.
  • Most Recent Events

    • 23 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 27 Jun 2012 Planned end date changed from 1 May 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 27 Jun 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01630057).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top